Detalles de la búsqueda
1.
Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer.
Br J Cancer
; 130(11): 1828-1840, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38600325
2.
Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer.
Br J Cancer
; 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38760444
3.
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial.
Lancet
; 401(10394): 2124-2137, 2023 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37302395
4.
Outcome of different radiotherapy strategies after breast conserving surgery in patients with ductal carcinoma in situ (DCIS).
Acta Oncol
; 62(9): 1045-1051, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37571927
5.
The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)-results from the UK Sloane Project.
Br J Cancer
; 127(12): 2125-2132, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36224403
6.
Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave.
Br J Cancer
; 127(7): 1289-1295, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35840733
7.
Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project.
Br J Cancer
; 124(5): 1009-1017, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33199800
8.
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast.
Br J Cancer
; 125(10): 1443-1449, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34408284
9.
Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London.
Br J Cancer
; 125(7): 939-947, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34400804
10.
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
Lancet
; 395(10237): 1613-1626, 2020 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32580883
11.
Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.
Blood
; 133(10): 1130-1139, 2019 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30573632
12.
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years.
Breast Cancer Res
; 21(1): 58, 2019 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31060593
13.
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.
Am J Hum Genet
; 99(4): 903-911, 2016 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27640304
14.
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience.
Breast Cancer Res Treat
; 174(3): 731-740, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30656459
15.
An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.
Hum Mol Genet
; 25(17): 3863-3876, 2016 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27402876
16.
MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours.
Br J Cancer
; 118(2): 277-284, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29315289
17.
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.
Am J Hum Genet
; 97(1): 22-34, 2015 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26073781
18.
Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Am J Hum Genet
; 96(1): 5-20, 2015 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-25529635
19.
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Lancet
; 390(10099): 1048-1060, 2017 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28779963
20.
SOX11 promotes invasive growth and ductal carcinoma in situ progression.
J Pathol
; 243(2): 193-207, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28707729